Paclitaxel poliglumex (CT-2103) [Xyotax] vs. paclitaxel for the treatment of women with chemotherapy-naive advanced non-small cell lung cancer who are performance status 2

Trial Profile

Paclitaxel poliglumex (CT-2103) [Xyotax] vs. paclitaxel for the treatment of women with chemotherapy-naive advanced non-small cell lung cancer who are performance status 2

Discontinued
Phase of Trial: Phase III

Latest Information Update: 26 Jul 2014

At a glance

  • Drugs Paclitaxel poliglumex (Primary) ; Paclitaxel
  • Indications Non-small cell lung cancer
  • Focus Registrational; Therapeutic Use
  • Acronyms PIONEER-1
  • Sponsors CTI BioPharma
  • Most Recent Events

    • 09 Dec 2006 Status change
    • 07 Nov 2006 Status change
    • 09 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top